Literature DB >> 10092714

Cardioversion of paroxysmal atrial fibrillation in the emergency department.

J A Michael1, I G Stiell, S Agarwal, D P Mandavia.   

Abstract

STUDY
OBJECTIVE: Patients presenting to the emergency department with acute atrial fibrillation are traditionally admitted to hospital. The objective of this study was to review the success and safety of ED cardioversion and discharge of patients with acute atrial fibrillation.
METHODS: This health records survey included a cohort sample of consecutive patients presenting with acute atrial fibrillation to the ED of a university-affiliated tertiary hospital. Patients who were in unstable condition on presentation, who had a complicating cardiac diagnosis, or those with other medical or surgical conditions requiring admission were excluded from the study analysis. Patient visit information was entered into a database that included demographics and clinical presentation, investigations, ED therapy, complications, consultations, disposition, and follow up. Patient visits were then categorized into the following groups: no ED intervention, spontaneous resolution, heart rate control, attempted chemical cardioversion, or electrical cardioversion. The data were analyzed using descriptive methods.
RESULTS: Of the 289 eligible patients seen during an 18-month period, 62% (180) underwent attempted chemical cardioversion with a 50% success rate and 28% (80) had attempted electrical cardioversion with a 89% success rate. Ninety-three percent of electrical cardioversions were performed by emergency physicians. There was an overall 6% (19) complication rate, 95% of which were regarded as minor. One patient had a complication caused by a rate control medication, which necessitated hospital admission. Ninety-seven percent (280) of the patients were discharged home directly from the ED.
CONCLUSION: Cardioversion and immediate discharge of patients who present to the ED with acute atrial fibrillation appears to be both safe and effective. This management approach should be prospectively evaluated in multiple settings.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092714     DOI: 10.1016/s0196-0644(99)70300-8

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  17 in total

1.  Surgical ablation for atrial fibrillation: an editorial.

Authors:  Pouya Nezafati; Mojgan Gharipour; Mohammad Hassan Nezafati
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

Review 2.  Acute management of atrial fibrillation with acute haemodynamic instability and in the postoperative setting.

Authors:  C J Mann; S Kendall; G Y H Lip
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

3.  Biphasic cardioversion of acute atrial fibrillation in the emergency department.

Authors:  G K Lo; D M Fatovich; A D Haig
Journal:  Emerg Med J       Date:  2006-01       Impact factor: 2.740

Review 4.  Cardioversion in Acute Atrial Fibrillation Without Anticoagulation.

Authors:  Ke Juhani Airaksinen; Wail Nammas; Ilpo Nuotio
Journal:  J Atr Fibrillation       Date:  2013-12-31

Review 5.  Managing atrial fibrillation.

Authors:  Clare L Atzema; Tyler W Barrett
Journal:  Ann Emerg Med       Date:  2015-02-18       Impact factor: 5.721

6.  Emergency department procedural sedation for primary electrical cardioversion - a comparison with procedural sedations for other reasons.

Authors:  Michael Butler; Patrick Froese; Peter Zed; George Kovacs; Robert MacKinley; Kirk Magee; Mary-Lynn Watson; Samuel G Campbell
Journal:  World J Emerg Med       Date:  2017

Review 7.  Pharmacological cardioversion of atrial fibrillation: current management and treatment options.

Authors:  Giuseppe Boriani; Igor Diemberger; Mauro Biffi; Cristian Martignani; Angelo Branzi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  A dedicated cardioversion unit for the treatment of atrial fibrillation. Reducing costs by optimizing processes.

Authors:  C Knackstedt; M Becker; K Mischke; R Pauling; H P Brunner-La Rocca; P Schauerte
Journal:  Herz       Date:  2011-11-19       Impact factor: 1.443

9.  Safety of cardioversion in atrial fibrillation lasting less than 48 h without post-procedural anticoagulation in patients at low cardioembolic risk.

Authors:  Andrea Tampieri; Valentina Cipriano; Fabrizio Mucci; Anna Maria Rusconi; Tiziano Lenzi; Patrizia Cenni
Journal:  Intern Emerg Med       Date:  2016-12-26       Impact factor: 3.397

Review 10.  Emergency management of atrial fibrillation.

Authors:  A Wakai; J O O'Neill
Journal:  Postgrad Med J       Date:  2003-06       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.